PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9349746-0	1997	Prevalent decrease of the EGF content in the periurethral zone of BPH tissue induced by treatment with finasteride or flutamide.	Flutamide	118-127	epidermal growth factor	Homo sapiens	26-29	
9349746-1	1997	The aim of the present investigation is to verify whether treatment with Finasteride or Flutamide influences the regional distribution of testosterone (T), dihydrotestosterone (DHT), and epidermal growth factor (EGF) in benign prostatic hyperplasia (BPH) tissue.	Flutamide	88-97	epidermal growth factor	Homo sapiens	187-210	
9349746-1	1997	The aim of the present investigation is to verify whether treatment with Finasteride or Flutamide influences the regional distribution of testosterone (T), dihydrotestosterone (DHT), and epidermal growth factor (EGF) in benign prostatic hyperplasia (BPH) tissue.	Flutamide	88-97	epidermal growth factor	Homo sapiens	212-215	
9228827-7	1997	Moreover we found that Testosterone, DHT and EGF are mainly concentrated in the periurethral zone in human BPH and long term treatment with Finasteride and with Flutamide modify the distribution and concentration of these factors.	Flutamide	161-170	epidermal growth factor	Homo sapiens	45-48	
9349746-5	1997	In the Flutamide group, DHT is not modified, T is increased (P = 0.045), and EGF is decreased in total tissue (P < 0.02) and in the periurethral zone (P < 0.01).	Flutamide	7-16	epidermal growth factor	Homo sapiens	77-80